Silvina Iluț, Adina Stan, Imelda Rahovan, Elian Hapca, Stefan Strilciuc & Dafin Muresanu. (2023) Variants of Amyotrophic lateral sclerosis and rehabilitation: an overview. Balneo and PRM Research Journal 14:Vol.14, no.2, pages 559.
Crossref
Silvina Iluț, Adina Stan, Imelda Rahovan, Elian Hapca, Ioana Zmaranda, Stefan Strilciuc & Dafin F. Muresanu. (2023) Variants of Amyotrophic lateral sclerosis and rehabilitation: an overview. Balneo and PRM Research Journal 14:Vol.14, no.2, pages 559.
Crossref
Maize C. Cao, Erin E. Cawston, Grace Chen, Collin Brooks, Jeroen Douwes, Dave McLean, E. Scott Graham, Mike Dragunow & Emma L. Scotter. (2022) Serum biomarkers of neuroinflammation and blood-brain barrier leakage in amyotrophic lateral sclerosis. BMC Neurology 22:1.
Crossref
Joyeta Ghosh. (2021) MULTIPLE SCLEROSIS, MITOCHONDRIA AND DIET THERAPY: AN OVERVIEW. GLOBAL JOURNAL FOR RESEARCH ANALYSIS, pages 132-135.
Crossref
Qionghua Sun, Xue Zhao, Siyuan Li, Fei Yang, Hongfen Wang, Fang Cui & Xusheng Huang. (2020) CSF Neurofilament Light Chain Elevation Predicts ALS Severity and Progression. Frontiers in Neurology 11.
Crossref
Germán Sánchez-Díaz, Francisco Escobar, Hannah Badland, Greta Arias-Merino, Manuel Posada de la Paz & Verónica Alonso-Ferreira. (2018) Geographic Analysis of Motor Neuron Disease Mortality and Heavy Metals Released to Rivers in Spain. International Journal of Environmental Research and Public Health 15:11, pages 2522.
Crossref
Antonio Scarafino, Eustachio D’Errico, Alessandro Introna, Angela Fraddosio, Eugenio Distaso, Irene Tempesta, Antonella Morea, Antonella Mastronardi, Rosaria Leante, Maddalena Ruggieri, Mariangela Mastrapasqua & Isabella Laura Simone. (2018) Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis. Journal of Neurology 265:10, pages 2353-2362.
Crossref
Alexandre Foito, Gordon J. McDougall & Derek Stewart. 2018. Annual Plant Reviews online. Annual Plant Reviews online
105
148
.
Christopher A. Shaw. 2017. Neural Dynamics of Neurological Disease. Neural Dynamics of Neurological Disease
301
354
.
E. Longinetti, D. Mariosa, H. Larsson, C. Almqvist, P. Lichtenstein, W. Ye & F. Fang. (2016) Physical and cognitive fitness in young adulthood and risk of amyotrophic lateral sclerosis at an early age. European Journal of Neurology 24:1, pages 137-142.
Crossref
Aurélia Vernay, Ludivine Therreau, Béatrice Blot, Valérie Risson, Sylvie Dirrig-Grosch, Robin Waegaert, Thiebault Lequeu, François Sellal, Laurent Schaeffer, Rémy Sadoul, Jean-Philippe Loeffler & Frédérique René. (2016)
A transgenic mouse expressing CHMP2B
intron5
mutant in neurons develops histological and behavioural features of amyotrophic lateral sclerosis and frontotemporal dementia
. Human Molecular Genetics 25:15, pages 3341-3360.
Crossref
M. Cosottini, G. Donatelli, M. Costagli, E. Caldarazzo Ienco, D. Frosini, I. Pesaresi, L. Biagi, G. Siciliano & M. Tosetti. (2016) High-Resolution 7T MR Imaging of the Motor Cortex in Amyotrophic Lateral Sclerosis. American Journal of Neuroradiology 37:3, pages 455-461.
Crossref
M. Costagli, G. Donatelli, L. Biagi, E. Caldarazzo Ienco, G. Siciliano, M. Tosetti & M. Cosottini. (2016) Magnetic susceptibility in the deep layers of the primary motor cortex in Amyotrophic Lateral Sclerosis. NeuroImage: Clinical 12, pages 965-969.
Crossref
Alida Spalloni & Patrizia Longone. (2016) Cognitive impairment in amyotrophic lateral sclerosis, clues from the SOD1 mouse. Neuroscience & Biobehavioral Reviews 60, pages 12-25.
Crossref
. 2016. Imaging in Neurology. Imaging in Neurology
243
.
. 2016. Diagnostic Imaging: Brain. Diagnostic Imaging: Brain
972
975
.
Caroline Seer, Stefanie Fürkötter, Maj-Britt Vogts, Florian Lange, Susanne Abdulla, Reinhard Dengler, Susanne Petri & Bruno Kopp. (2015) Executive Dysfunctions and Event-Related Brain Potentials in Patients with Amyotrophic Lateral Sclerosis. Frontiers in Aging Neuroscience 7.
Crossref
Joseph Goveas, Laurence O’Dwyer, Mario Mascalchi, Mirco Cosottini, Stefano Diciotti, Silvia De Santis, Luca Passamonti, Carlo Tessa, Nicola Toschi & Marco Giannelli. (2015) Diffusion-MRI in neurodegenerative disorders. Magnetic Resonance Imaging 33:7, pages 853-876.
Crossref
Leslie I. Grad, Sarah M. Fernando & Neil R. Cashman. (2015) From molecule to molecule and cell to cell: Prion-like mechanisms in amyotrophic lateral sclerosis. Neurobiology of Disease 77, pages 257-265.
Crossref
Jeffrey Rosenfeld & Michael J. Strong. (2015) Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease. Neurotherapeutics 12:2, pages 317-325.
Crossref
Christopher J Donnelly, Jonathan C Grima & Rita Sattler. (2014) Aberrant RNA homeostasis in amyotrophic lateral sclerosis: potential for new therapeutic targets?. Neurodegenerative Disease Management 4:6, pages 417-437.
Crossref
Andrea Vianello & Alessandra Concas. (2014) Tracheostomy ventilation in ALS: A Japanese bias. Journal of the Neurological Sciences 344:1-2, pages 3-4.
Crossref
Rachel N. Smith, Amruta S. Agharkar & Eric B. Gonzales. (2014) A review of creatine supplementation in age-related diseases: more than a supplement for athletes. F1000Research 3, pages 222.
Crossref
Angela M. Malek, Aaron Barchowsky, Robert Bowser, Terry Heiman-Patterson, David Lacomis, Sandeep Rana, Ada Youk, David Stickler, Daniel T. Lackland & Evelyn O. Talbott. (2014) Environmental and Occupational Risk Factors for Amyotrophic Lateral Sclerosis: A Case-Control Study. Neurodegenerative Diseases 14:1, pages 31-38.
Crossref
Antonio Paoli, Antonino Bianco, Ernesto Damiani & Gerardo Bosco. (2014) Ketogenic Diet in Neuromuscular and Neurodegenerative Diseases. BioMed Research International 2014, pages 1-10.
Crossref
G.M. Willett & N.S. Norton. 2014. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Amit Prabhakar, Christopher Paul Owen & Alan David Kaye. (2013) Anesthetic management of the patient with amyotrophic lateral sclerosis. Journal of Anesthesia 27:6, pages 909-918.
Crossref
M. di Paolo, L. Evangelisti & N. Ambrosino. (2013) Unexpected death of a ventilator-dependent amyotrophic lateral sclerosis patient. Revista Portuguesa de Pneumologia 19:4, pages 175-178.
Crossref
M. di Paolo, L. Evangelisti & N. Ambrosino. (2013) Unexpected death of a ventilator-dependent amyotrophic lateral sclerosis patient. Revista Portuguesa de Pneumologia (English Edition) 19:4, pages 175-178.
Crossref
M. Giagheddu, G. Puggioni, P. Tacconi, M. I. Pirastru, A. Cannas, G. Tamburini & S. Congia. (2013) Amyotrophic lateral sclerosis in Sardinia (Italy): epidemiologic features from 1957 to 2000. Acta Neurologica Scandinavica 127:4, pages 251-259.
Crossref
Ramón Palacios Bote & M.A. Fernández-Gil. (2013) Degeneration of the Brainstem. Seminars in Ultrasound, CT and MRI 34:2, pages 142-152.
Crossref
Deanna Britton, Stuart Cleary & Robert Miller. (2013) What is ALS and What is the Philosophy of Care?. Perspectives on Swallowing and Swallowing Disorders (Dysphagia) 22:1, pages 4-11.
Crossref
R. Tortelli, M. Ruggieri, R. Cortese, E. D'Errico, R. Capozzo, A. Leo, M. Mastrapasqua, S. Zoccolella, R. Leante, P. Livrea, G. Logroscino & I. L. Simone. (2012) Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression. European Journal of Neurology 19:12, pages 1561-1567.
Crossref
Rita Sattler & Jeffrey Rothstein. 2012. Neuroglia. Neuroglia
810
824
.
Daniele CapitanioMichele VassoAntonia RattiGiuliano GrignaschiManuela VoltaManuela MoriggiCristina DalenoCaterina BendottiVincenzo SilaniCecilia Gelfi. (2012)
Molecular Signatures of Amyotrophic Lateral Sclerosis Disease Progression in Hind and Forelimb Muscles of an SOD1
G93A
Mouse Model
. Antioxidants & Redox Signaling 17:10, pages 1333-1350.
Crossref
Wei Zhao, Merina Varghese, Prashant Vempati, Anastasiya Dzhun, Alice Cheng, Jun Wang, Dale Lange, Amanda Bilski, Irene Faravelli & Giulio Maria Pasinetti. (2012) Caprylic Triglyceride as a Novel Therapeutic Approach to Effectively Improve the Performance and Attenuate the Symptoms Due to the Motor Neuron Loss in ALS Disease. PLoS ONE 7:11, pages e49191.
Crossref
Joanna Tarasiuk, Alina Kułakowska, Wiesław Drozdowski, Johannes Kornhuber & Piotr Lewczuk. (2012) CSF markers in amyotrophic lateral sclerosis. Journal of Neural Transmission 119:7, pages 747-757.
Crossref
Pietro Cipresso, Laura Carelli, Federica Solca, Daniela Meazzi, Paolo Meriggi, Barbara Poletti, Dorothée Lulé, Albert C. Ludolph, Vincenzo Silani & Giuseppe Riva. (2012) The use of P300‐based BCIs in amyotrophic lateral sclerosis: from augmentative and alternative communication to cognitive assessment. Brain and Behavior 2:4, pages 479-498.
Crossref
Hyunjin Oh, Mo-Kyung Sin, Karen G. Schepp & Smi Choi-Kwon. (2012) Depressive Symptoms and Functional Impairment Among Amyotrophic Lateral Sclerosis Patients in South Korea. Rehabilitation Nursing 37:3, pages 136-144.
Crossref
Miguel Moreno-Martet, Leyre Mestre, Frida Loría, Carmen Guaza, Javier Fernández-Ruiz & Eva de Lago. (2012) Identification of receptors and enzymes for endocannabinoids in NSC-34 cells: Relevance for in vitro studies with cannabinoids in motor neuron diseases. Neuroscience Letters 508:2, pages 67-72.
Crossref
Petra Steinacker, Lubin Fang, Jens Kuhle, Axel Petzold, Hayrettin Tumani, Albert C. Ludolph, Markus Otto & Johannes Brettschneider. (2011) Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis. PLoS ONE 6:8, pages e23600.
Crossref
Nobutoshi Morimoto, Kentaro Deguchi, Kota Sato, Taijun Yunoki, Shoko Deguchi, Yasuyuki Ohta, Tomoko Kurata, Yoshiki Takao, Yoshio Ikeda, Tohru Matsuura & Koji Abe. (2011) Correlation of cerebral spinal fluid pH and HCO3- with disease progression in ALS. Journal of the Neurological Sciences 307:1-2, pages 74-78.
Crossref
Maria Piotrkiewicz & Irena Hausmanowa‐Petrusewicz. (2011) Motoneuron afterhyperpolarisation duration in amyotrophic lateral sclerosis. The Journal of Physiology 589:11, pages 2745-2754.
Crossref
Andrea Vianello, Giovanna Arcaro, Arianna Palmieri, Mario Ermani, Fausto Braccioni, Federico Gallan, Gianni Soraru'Elena Pegoraro. (2011) Survival and quality of life after tracheostomy for acute respiratory failure in patients with amyotrophic lateral sclerosis. Journal of Critical Care 26:3, pages 329.e7-329.e14.
Crossref
Manzoor Ahmed & Michael Phillips. 2011. Problem Solving in Neuroradiology. Problem Solving in Neuroradiology
333
360
.
Jesse R. McLean & Janice Robertson. 2011. Cytoskeleton of the Nervous System. Cytoskeleton of the Nervous System
201
224
.
David R. Brown. (2010) Metalloproteins and neuronal death. Metallomics 2:3, pages 186-194.
Crossref
Johannes Brettschneider, Vera Lehmensiek, Helga Mogel, Martin Pfeifle, Johannes Dorst, Corinna Hendrich, Albert C. Ludolph & Hayrettin Tumani. (2010) Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS). Neuroscience Letters 468:1, pages 23-27.
Crossref
Shizuo Ohnishi, Hidefumi Ito, Yasuhiro Suzuki, Yasushi Adachi, Reika Wate, Jianhua Zhang, Satoshi Nakano, Hirofumi Kusaka & Susumu Ikehara. (2009) Intra-bone marrow-bone marrow transplantation slows disease progression and prolongs survival in G93A mutant SOD1 transgenic mice, an animal model mouse for amyotrophic lateral sclerosis. Brain Research 1296, pages 216-224.
Crossref
Beatrice A. Golomb, Edwin K. Kwon, Sabrina Koperski & Marcella A. Evans. (2009) Amyotrophic Lateral Sclerosis-Like Conditions in Possible Association with Cholesterol-Lowering Drugs. Drug Safety 32:8, pages 649-661.
Crossref
J. Hegedus, C. T. Putman & T. Gordon. (2009) Progressive motor unit loss in the G93A mouse model of amyotrophic lateral sclerosis is unaffected by gender. Muscle & Nerve 39:3, pages 318-327.
Crossref
M. Nelles, W. Block, F. Träber, U. Wüllner, H.H. Schild & H. Urbach. (2008)
Combined 3T Diffusion Tensor Tractography and
1
H-MR Spectroscopy in Motor Neuron Disease
. American Journal of Neuroradiology 29:9, pages 1708-1714.
Crossref
Valentin K. Gribkoff & Michael E. Bozik. (2008) KNS-760704 [(6R)-4,5,6,7-tetrahydro-N6-propyl-2, 6-benzothiazole-diamine dihydrochloride monohydrate] for the Treatment of Amyotrophic Lateral Sclerosis. CNS Neuroscience & Therapeutics 14:3, pages 215-226.
Crossref
Elsa Raibon, Lisa Marie Todd & Thomas Möller. (2008) Glial Cells in ALS: The Missing Link?. Physical Medicine and Rehabilitation Clinics of North America 19:3, pages 441-459.
Crossref
Jeffrey Rosenfeld & Amy Ellis. (2008) Nutrition and Dietary Supplements in Motor Neuron Disease. Physical Medicine and Rehabilitation Clinics of North America 19:3, pages 573-589.
Crossref
Robert H. Andres, Angélique D. Ducray, Uwe Schlattner, Theo Wallimann & Hans Rudolf Widmer. (2008) Functions and effects of creatine in the central nervous system. Brain Research Bulletin 76:4, pages 329-343.
Crossref
K. Kollewe, R. Dengler & S. Petri. (2008) Amyotrophe LateralskleroseAmyotrophic lateral sclerosis. Der Nervenarzt 79:6, pages 653-661.
Crossref
Roanne Preston. 2009. Obstetric Anesthesia and Uncommon Disorders. Obstetric Anesthesia and Uncommon Disorders
191
214
.
Jonathan RileyWalter SweeneyNicholas Boulis. (2008) Shifting the balance: cell-based therapeutics as modifiers of the amyotrophic lateral sclerosis–specific neuronal microenvironment. Neurosurgical Focus 24:3-4, pages E10.
Crossref
Robert M. Miller & Deanna Britton. (2007) Experience With Amyotrophic Lateral Sclerosis: Incidence, Pathology, and Treatment Considerations. Perspectives on Gerontology 12:1, pages 17-22.
Crossref
Gianluca Marucci, Luca Morandi, Ilaria Bartolomei, Fabrizio Salvi, Annalisa Pession, Alberto Righi, Giuseppe Lauria & Maria P. Foschini. (2007) Amyotrophic lateral sclerosis with mutation of the Cu/Zn superoxide dismutase gene (SOD1) in a patient with Down syndrome. Neuromuscular Disorders 17:9-10, pages 673-676.
Crossref
L. L. Morselli, P. Bongioanni, M. Genovesi, R. Licitra, B. Rossi, L. Murri, F. Bogazzi, E. Cecconi, E. Martino & M. Gasperi. (2014) Impairment of GH secretion in amyotrophic lateral sclerosis is not affected by riluzole treatment. Journal of Endocrinological Investigation 30:9, pages 767-770.
Crossref
Theo Wallimann, Malgorzata Tokarska‐Schlattner, Dietbert Neumann, Richard M. Epand, Raquel F. Epand, Robert H. Andres, Hans Rudolf Widmer, Thorsten Hornemann, Valdur Saks, Irina Agarkova & Uwe Schlattner. 2007. Molecular System Bioenergetics. Molecular System Bioenergetics
195
264
.
Karin Widl, Johannes Brettschneider, Dagmar Schattauer, Sigurd Süßmuth, Roman Huber, Albert C. Ludolph & Hayrettin Tumani. (2007) Erythropoietin in Cerebrospinal Fluid: Age-related Reference Values and Relevance in Neurological Disease. Neurochemical Research 32:7, pages 1163-1168.
Crossref
Jennifer L. Shoemaker, Kathryn A. Seely, Ronald L. Reed, John P. Crow & Paul L. Prather. (2006) The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset. Journal of Neurochemistry 101:1, pages 87-98.
Crossref
Lauren B. ElmanDavid J. HoughtonGregory F. WuHoward I. HurtigClyde E. MarkowitzLeo McCluskey. (2007) Palliative Care in Amyotrophic Lateral Sclerosis, Parkinson's Disease, and Multiple Sclerosis. Journal of Palliative Medicine 10:2, pages 433-457.
Crossref
Johannes Brettschneider, Karin Widl, Dagmar Schattauer, Albert C. Ludolph & Hayrettin Tumani. (2007) Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis. Neuroscience Letters 416:3, pages 257-260.
Crossref
Neil S. Norton & Gilbert Willett. 2007. xPharm: The Comprehensive Pharmacology Reference. xPharm: The Comprehensive Pharmacology Reference
1
5
.
Zhong Zhao, Dale J Lange, Andrei Voustianiouk, Donal MacGrogan, Lap Ho, Jason Suh, Nelson Humala, Meenakshisundaram Thiyagarajan, Jun Wang & Giulio M Pasinetti. (2006) A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neuroscience 7:1.
Crossref
L. L. Morselli, P. Bongioanni, M. Genovesi, R. Licitra, B. Rossi, L. Murri, G. Rossi, E. Martino & M. Gasperi. (2006) Growth hormone secretion is impaired in amyotrophic lateral sclerosis. Clinical Endocrinology 65:3, pages 385-388.
Crossref
C. de Burgos Lunar, M.A. de Diego Villalón & J.R. Moracho Sánchez. (2006) Atrofia de la musculatura de la mano: a propósito de un caso. SEMERGEN - Medicina de Familia 32:4, pages 188-191.
Crossref
J. Brettschneider, A. Petzold, S. D. Süßmuth, A. C. Ludolph & H. Tumani. (2006) Axonal damage markers in cerebrospinal fluid are increased in ALS. Neurology 66:6, pages 852-856.
Crossref
Jeffrey RosenfeldMichael Swash. (2006) What’s in a name?. Neurology 66:5, pages 624-625.
Crossref
Thais Federici & Nicholas M. Boulis. (2006) Gene-based treatment of motor neuron diseases. Muscle & Nerve 33:3, pages 302-323.
Crossref
Richelle Hemendinger, Jay Wang, Saafan Malik, Rafal Persinski, Jane Copeland, Dwaine Emerich, Paul Gores, Craig Halberstadt & Jeffrey Rosenfeld. (2005) Sertoli cells improve survival of motor neurons in SOD1 transgenic mice, a model of amyotrophic lateral sclerosis. Experimental Neurology 196:2, pages 235-243.
Crossref
Mirco Cosottini, Marco Giannelli, Gabriele Siciliano, Guido Lazzarotti, Maria Chiara Michelassi, Alberto Del Corona, Carlo Bartolozzi & Luigi Murri. (2005) Diffusion-Tensor MR Imaging of Corticospinal Tract in Amyotrophic Lateral Sclerosis and Progressive Muscular Atrophy. Radiology 237:1, pages 258-264.
Crossref
John P. Crow, Noel Y. Calingasan, Junyu Chen, Julie Lynch Hill & M. Flint Beal. (2005) Manganese porphyrin given at symptom onset markedly extends survival of ALS mice. Annals of Neurology 58:2, pages 258-265.
Crossref
Yoon Hee Chung, Kyeung Min Joo, Ryoung Hee Nam, Mi Haeng Cho, Dae Jin Kim, Won Bok Lee & Choong Ik Cha. (2005) Decreased expression of calretinin in the cerebral cortex and hippocampus of SOD1G93A transgenic mice. Brain Research 1035:1, pages 105-109.
Crossref
Edith G McGeer & Patrick L McGeer. (2005) Pharmacologic Approaches to the Treatment of Amyotrophic Lateral Sclerosis. BioDrugs 19:1, pages 31-37.
Crossref
Jun Xie, Keytam S. Awad & Qing Guo. (2005) RNAi knockdown of Par-4 inhibits neurosynaptic degeneration in ALS-linked mice. Journal of Neurochemistry 92:1, pages 59-71.
Crossref
Javier Fernández-Ruiz, Sara González, Julián Romero & José Antonio Ramos. 2005. Cannabinoids as Therapeutics. Cannabinoids as Therapeutics
79
109
.
James O’Callaghan & Krishnan Sriram. 2004. The Role of Glia in Neurotoxicity, Second Edition. The Role of Glia in Neurotoxicity, Second Edition
141
171
.
Yoon Hee Chung, Kyeung Min Joo, Yun Jung Lee, Won Bok Lee, Kyung Hoon Lee & Choong Ik Cha. (2004) Enhanced expression of erythropoietin in the central nervous system of SOD1G93A transgenic mice. Brain Research 1016:2, pages 272-280.
Crossref
Olivier Sorg. (2004) Oxidative stress: a theoretical model or a biological reality?. Comptes Rendus Biologies 327:7, pages 649-662.
Crossref
Andrew Eisen. 2004. Advances in Clinical Neurophysiology, Proceedings of the 27th International Congress of Clinical Neurophysiology, AAEM 50th Anniversary and 57th Annual Meeting of the ACNS Joint Meeting. Advances in Clinical Neurophysiology, Proceedings of the 27th International Congress of Clinical Neurophysiology, AAEM 50th Anniversary and 57th Annual Meeting of the ACNS Joint Meeting
187
190
.